We would love to hear your thoughts about our site and services, please take our survey here.
Here are the dividend numbers -
https://www.dividenddata.co.uk/dividend-yield.py?epic=GSK
Define “progressive”!?
Not really “news”. Article from 19 August 2022.
https://www.pmlive.com/pharma_news/gsk_awarded_first-ever_unicef_contract_for_malaria_vaccine_in_deal_worth_170m_1453562?SQ_ACTION=clear_design_name&full=true
You can find daily share prices on Yahoo Finance. The record date for the GSK share consolidation was 8pm on 18 July 2022.
Here is the Link -
https://uk.finance.yahoo.com/quote/GSK.L/history?p=GSK.L
This webpage perhaps gives a more realistic representation of the current GSK Yield given that its former annual historic payout of 80p has been cut significantly -
https://www.dividenddata.co.uk/dividend-yield.py?epic=GSK
From what I can gather, for the time being they seem to be using a “notional” annualised dividend figure of 100p per share for GSK - which gives you the Yield percentages quoted in your post. The number that you have worked out for yourself is nearer the mark, but the 2022 annual dividend is not in fact 65p (4 times 16.25p).
The forecast dividend for the whole of 2023 is 56.25p per share. (The 45p figure quoted has been increased to reflect the Share Consolidation.)
GSK Press Release extract - 18 July 2022:
“Dividends
GSK has previously stated that it expected to declare a 27p per share dividend for the first half of 2022, a 22p per share dividend for the second half of 2022 and a 45p per share dividend for 2023, but that these targeted dividends per share would increase in step with the GSK Share Consolidation to maintain the same aggregate dividend pay-out in absolute Pound Sterling terms. Accordingly, using the consolidation ratio, GSK’s expected dividend for the second quarter of 2022 converts to 16.25p per new ordinary share (taking into account the dividend of 14p per share paid for the first quarter of 2022), the expected dividend for the second half of 2022 converts to 27.5p per new ordinary share and the expected dividend for 2023 converts to 56.25p per new ordinary share. GSK expects to publish its results for the second quarter of 2022 on Wednesday 27 July 2022 which will confirm the dividend to be declared for that quarter.”
Apologies - CORRECTION:
The market value of 4 “new” GSK shares plus 5 Haleon shares was, more or less, the same on Tuesday 19 July 2022 as 5 “old” GSK share was on the previous Friday i.e. before the Demerger and share consolidation happened.
GSK announced the completion of the Demerger (the “split”) of Haleon plc from GSK at 7 a.m. on Monday 18 July 2022, and trading in the new Haleon plc shares commenced on that date.
After the London market closed on that Monday, the old GSK shares were then consolidated at 6 p.m. on a 4 new for 5 old basis, and trading in the new GSK shares commenced on the morning of Tuesday 19 July.
The market value of 1 new GSK share plus 1 Haleon share was, more or less, the same on Tuesday as 1 old GSK share was on the previous Friday i.e. before the Demerger and share consolidation happened.
There was NO “one week delay”.
A short time lag between the date of the GSK share consolidation and your ISA manager updating their own ISA share records is understandable - but to imply that this was GSK’s fault is not correct.
When shares go “ex-dividend” on the London Stock Exchange then all of the market transactions are WITHOUT any entitlement to any dividends that have already been declared by the Company.
If you sell GSK shares today then the buyer has no right to receive the 6 October dividend - you (the seller) will be paid it by the Company, and it is yours to keep.